A detailed history of Citigroup Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Citigroup Inc holds 146,276 shares of TECH stock, worth $11.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
146,276
Previous 141,366 3.47%
Holding current value
$11.3 Million
Previous $10.1 Million 15.4%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$70.96 - $82.35 $348,413 - $404,338
4,910 Added 3.47%
146,276 $11.7 Million
Q2 2024

Aug 12, 2024

SELL
$62.12 - $84.15 $3.24 Million - $4.39 Million
-52,222 Reduced 26.98%
141,366 $10.1 Million
Q1 2024

May 10, 2024

BUY
$65.98 - $77.09 $5.84 Million - $6.82 Million
88,436 Added 84.1%
193,588 $13.6 Million
Q4 2023

Feb 09, 2024

BUY
$52.83 - $78.22 $443,296 - $656,344
8,391 Added 8.67%
105,152 $8.11 Million
Q3 2023

Nov 09, 2023

SELL
$67.52 - $89.42 $292,226 - $387,009
-4,328 Reduced 4.28%
96,761 $6.59 Million
Q2 2023

Aug 10, 2023

BUY
$73.76 - $85.98 $505,108 - $588,791
6,848 Added 7.27%
101,089 $8.25 Million
Q1 2023

May 11, 2023

BUY
$71.62 - $86.62 $947,532 - $1.15 Million
13,230 Added 16.33%
94,241 $6.99 Million
Q4 2022

Feb 09, 2023

BUY
$80.67 - $352.29 $4.57 Million - $20 Million
56,701 Added 233.24%
81,011 $6.71 Million
Q3 2022

Nov 10, 2022

BUY
$282.54 - $391.85 $1.61 Million - $2.23 Million
5,701 Added 30.64%
24,310 $6.9 Million
Q2 2022

Aug 10, 2022

SELL
$322.67 - $449.65 $2.23 Million - $3.1 Million
-6,900 Reduced 27.05%
18,609 $6.45 Million
Q1 2022

May 12, 2022

SELL
$353.85 - $487.79 $759,715 - $1.05 Million
-2,147 Reduced 7.76%
25,509 $11 Million
Q4 2021

Feb 10, 2022

SELL
$456.15 - $525.06 $5.9 Million - $6.79 Million
-12,937 Reduced 31.87%
27,656 $14.3 Million
Q3 2021

Nov 10, 2021

BUY
$444.87 - $538.88 $18.1 Million - $21.9 Million
40,593 New
40,593 $19.7 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.02B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.